Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Clinical trial NCT05661942 · COMPLETED

Trial details

NCT number: NCT05661942
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation With Rapid Ventricular Response Hypotension Drug-Induced

Start date: 2022-11-30
Primary completion: 2024-11-20
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.